SEC Form 4 · accession 0001127602-17-026651
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert N Marchio II
Officer — Chief Accounting & Adm Officer
Period of report
Aug 29, 2017
Accepted (ET)
Aug 29, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 29, 2017 | S | 2,500 | $10.42 | D | 3,361 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $10.39 to $10.47 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.